Today I close this cycle of posts about the last programming period of H2020 completing the puzzle with one of the more important and transversal areas of the program: Information and Communication Technologies, the so-called ICT.
Moving forward the H2020 puzzle, today I will put the focus on industry; not the “classical” industry concept that we all bear in our minds, but the so-called Industry 4.0 In Europe, the 64% of the private R&D investment is dedicated to manufacture, meaning that the 9% of the companies are dedicated to this sector. The importance of manufacture in Europe is also measured in terms of jobs, counting on more than 32 million of direct jobs, and in terms of revenue, reaching € 7,110 trillion.
Según trasladó el presidente Juncker en el discurso de 2017 sobre el estado de la Unión, los grandes escenarios que conducirán a una UE más unida, fuerte y democrática están detallados en el “Libro Blanco sobre el futuro de Europa”.
Plastic wastes management is one of the main global challenges we are currently facing. Within the packaging sector (the biggest one), only 14% are collected for recycling, and from those, 2% are incorporated to the value chain for producing new components. This means that plastic packaging is almost exclusively for single use, something to be really worried about, as they are non-biodegradable materials made with non-renewable sources (fossil).
In my post of April I try to show you the future health challenges that this last programming period is focusing on. We have completed half the H2020’s puzzle but there are still some pieces missing. Today I will go deeper into the challenge of building a more sustainable Europe.
In March I explained to you the challenges regarding social resilience and security. H2020’s puzzle has another important pieces like the one that is our topic today: health of the future.
Today I start with a series of posts in which I will explain what I have called "puzzle pieces" that make up the H2020 puzzle for this last programming period 2018-2020.
In my previous post we discussed about how SME companies face R&D strategies, specially in regards will public aids from the European Commission. Lets try to bring some light about the strategy of “BIG” companies related to the same topic.
My name is Irene Baena. I’m a biologist, currently working as a R&I consultant at RTDI. I have always feel very concerned about how human beings interact with nature. As a specie, we have escaped from nature regulation and altered the “normal” evolution pace of other species. Our resource consumption and population growth is going so fast it will be practically impossible to maintain this scheme without suffering devastating consequences.
My name is Reyes Sansegundo Romero, Proposals Coordinator and R&I Consultant at RTDI. I have been working for more than 7 years in National, European and International research projects management. I have accompanied hundreds of researchers throughout the life cycle of their projects, from the conception of the idea to the start-up, justification and exploitation of the financed projects.
I start this blog with the goal of making private companies and research institutions realize how important it is for them to have a correct strategy, roadmap and understanding of EU public aid programs when they decide they want to take that route within their organizations. During many years I have been dealing with many mistakes and approaches to face these programs, being the most important one a wrong approach and perception about what this brings to the table.
The Bio-Based Industries Joint Undertaking (BBI JU) has published the annual work plan and budget for 2018. As we already saw the nature of the BBI JU and the hot topics in previous blog entrances, this time we will focus on the main aspects to be considered if you are interested in applying for this call.
The call considers four strategic orientations already set in previous years:
Within the current economic and societal European context, health research is crucial to ensure the continuing health and well-being of all European citizens.
The Horizon 2020 Advisory Group for Societal Challenge 1, "Health, Demographic Change and Well-being" has raised the following research priorities regarding health as a whole:
Reducing wastes production and transforming them into new high value products will be a transversal objective within the last H2020 period, especially present in the societal challenges related to Food security & Bioeconomy (SC2), Climate & Environment (SC5), and the Leadership in Enabling and Industrial Technologies - Nanotechnologies, Advanced Materials, Advanced Manufacturing and Processing, and Biotechnology (LEIT-NMBP). This objective falls under the focus area “Connecting economic and environmental gains – the Circular Economy”, which will count with €941 million budget.
In the last centuries the relationship between human beings and forests has been based on the aggressive exploitation of their resources, without hardly taking into account the consequences.